Mapping the state of a pharmaceutical Co-precipitation process: An integrated process analytical technology (PAT) approach

AIChE Annual Meeting, Conference Proceedings

Volumn , Issue , 2006, Pages

  Wu, Huiquan ^a   Khan, Mansoor A ^a  

^a Office of Testing and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053844134     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (5)

1. Khan, Mansoor A., et al.(1994), "Optimization of process variables for the preparation of ibuprofen coprecipitates with Eudragit S100," International Journal of Pharmaceutics, 102, pp.185-92.
2. Zaghloul, A.A., Faltinek, J., Vaithiyalingam, S.R.,Reddy, I.K., and Khan, Mansoor A.(2001), "Naproxen-Eudragit microspheres : screening of process and formulation variables for the preparation of extended release tablets", Pharmazie. 56(4), pp.321-324.
3. FDA (2004). "Guidance for Industry. PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance", http://www.fda.gov/cder/auidance/6419fnl.pdf
4. Yu, Lawrence Y.,Lionberger, Robert A., Raw, Andre S.,D'Costa, Rosario, Wu, Huiquan, Hussain, Ajaz S. (2004), "Applications of process analytical technology to crystallization processes,".Advanced Drug Delivery Reviews, 56(3), pp.349-369
5. Wu, Huiquan and Hussain, Ajaz S. (2005), "Use of PAT for Active Pharmaceutical Ingredient Crystallization Process Control," In: P. Horacek, M. Simandl, P. Zitek, editors: Preprints of the 2005 IFAC World Congress. Prague, Czech Republic, July 4-9, 2005. CD-ROM.